Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?
Rheumatoid arthritis (RA) is associated with a similar cardiovascular risk to that in diabetes, and therefore cardiovascular risk management (CV-RM) - that is, identification and treatment of cardiovascular risk factors (CRFs) - is mandatory. However, whether and to what extent this is done in daily...
Gespeichert in:
| Veröffentlicht in: | Arthritis research & therapy 2013-03, Vol.15 (2), p.111-111 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 111 |
|---|---|
| container_issue | 2 |
| container_start_page | 111 |
| container_title | Arthritis research & therapy |
| container_volume | 15 |
| creator | Peters, Mike J L Nurmohamed, Michael T |
| description | Rheumatoid arthritis (RA) is associated with a similar cardiovascular risk to that in diabetes, and therefore cardiovascular risk management (CV-RM) - that is, identification and treatment of cardiovascular risk factors (CRFs) - is mandatory. However, whether and to what extent this is done in daily clinical practice is unknown. In a retrospective cohort investigation, CV-RM was therefore compared between rheumatologists and primary care physicians (PCPs). Remarkably, CRFs in RA were less frequently identified and managed by rheumatologists in comparison with PCPs. In addition, PCPs assessed CRFs less frequently in RA than in diabetes. Obviously, there is a clear need for improvement of CV-RM in RA and this should be a joint effort from the rheumatologist and the PCP. |
| doi_str_mv | 10.1186/ar4185 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3672756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1551022100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-a22c1ded96274ff21605b75494313e816ec5bab033b209937567b2715c0533a03</originalsourceid><addsrcrecordid>eNpVkctOwzAQRS0EoqXAJyCvEJuA30lYgFDFS6rEBtZmkjiNIY9iO634e1K1VLCa0czVuaM7CJ1Scklpoq7ACZrIPTSmIk4ixRXb3_VSjNCR9x-EMJYycYhGjEsqBBFj9D4FV9huCT7va3DYWf-JG2hhbhrTBmxb7CrTNxA6W2BwoXI2WH89tAavDPbB1jVewTBs57jsHA6VwaV1Pgw7s7g9Rgcl1N6cbOsEvT3cv06fotnL4_P0bhblXKkQAWM5LUyRKhaLsmRUEZnFUqSCU24SqkwuM8gI5xkjacpjqeKMxVTmRHIOhE_QzYa76LPGFPlwvINaL5xtwH3rDqz-v2ltpefdUnMVs4E2AC62ANd99cYH3Vifm7qG1nS911RKOgRIydrrfCPNXee9M-XOhhK9fofevGMQnv09aif7zZ__APVmheo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551022100</pqid></control><display><type>article</type><title>Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Peters, Mike J L ; Nurmohamed, Michael T</creator><creatorcontrib>Peters, Mike J L ; Nurmohamed, Michael T</creatorcontrib><description>Rheumatoid arthritis (RA) is associated with a similar cardiovascular risk to that in diabetes, and therefore cardiovascular risk management (CV-RM) - that is, identification and treatment of cardiovascular risk factors (CRFs) - is mandatory. However, whether and to what extent this is done in daily clinical practice is unknown. In a retrospective cohort investigation, CV-RM was therefore compared between rheumatologists and primary care physicians (PCPs). Remarkably, CRFs in RA were less frequently identified and managed by rheumatologists in comparison with PCPs. In addition, PCPs assessed CRFs less frequently in RA than in diabetes. Obviously, there is a clear need for improvement of CV-RM in RA and this should be a joint effort from the rheumatologist and the PCP.</description><identifier>ISSN: 1478-6354</identifier><identifier>EISSN: 1478-6362</identifier><identifier>DOI: 10.1186/ar4185</identifier><identifier>PMID: 23514404</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Arthritis, Rheumatoid - drug therapy ; Cardiovascular Diseases - drug therapy ; Diabetes Mellitus, Type 2 - drug therapy ; Female ; Humans ; Male ; Practice Patterns, Physicians' - statistics & numerical data ; Primary Health Care - statistics & numerical data</subject><ispartof>Arthritis research & therapy, 2013-03, Vol.15 (2), p.111-111</ispartof><rights>Copyright © 2013 BioMed Central Ltd 2013 BioMed Central Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-a22c1ded96274ff21605b75494313e816ec5bab033b209937567b2715c0533a03</citedby><cites>FETCH-LOGICAL-c366t-a22c1ded96274ff21605b75494313e816ec5bab033b209937567b2715c0533a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672756/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672756/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23514404$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peters, Mike J L</creatorcontrib><creatorcontrib>Nurmohamed, Michael T</creatorcontrib><title>Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?</title><title>Arthritis research & therapy</title><addtitle>Arthritis Res Ther</addtitle><description>Rheumatoid arthritis (RA) is associated with a similar cardiovascular risk to that in diabetes, and therefore cardiovascular risk management (CV-RM) - that is, identification and treatment of cardiovascular risk factors (CRFs) - is mandatory. However, whether and to what extent this is done in daily clinical practice is unknown. In a retrospective cohort investigation, CV-RM was therefore compared between rheumatologists and primary care physicians (PCPs). Remarkably, CRFs in RA were less frequently identified and managed by rheumatologists in comparison with PCPs. In addition, PCPs assessed CRFs less frequently in RA than in diabetes. Obviously, there is a clear need for improvement of CV-RM in RA and this should be a joint effort from the rheumatologist and the PCP.</description><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Practice Patterns, Physicians' - statistics & numerical data</subject><subject>Primary Health Care - statistics & numerical data</subject><issn>1478-6354</issn><issn>1478-6362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkctOwzAQRS0EoqXAJyCvEJuA30lYgFDFS6rEBtZmkjiNIY9iO634e1K1VLCa0czVuaM7CJ1Scklpoq7ACZrIPTSmIk4ixRXb3_VSjNCR9x-EMJYycYhGjEsqBBFj9D4FV9huCT7va3DYWf-JG2hhbhrTBmxb7CrTNxA6W2BwoXI2WH89tAavDPbB1jVewTBs57jsHA6VwaV1Pgw7s7g9Rgcl1N6cbOsEvT3cv06fotnL4_P0bhblXKkQAWM5LUyRKhaLsmRUEZnFUqSCU24SqkwuM8gI5xkjacpjqeKMxVTmRHIOhE_QzYa76LPGFPlwvINaL5xtwH3rDqz-v2ltpefdUnMVs4E2AC62ANd99cYH3Vifm7qG1nS911RKOgRIydrrfCPNXee9M-XOhhK9fofevGMQnv09aif7zZ__APVmheo</recordid><startdate>20130319</startdate><enddate>20130319</enddate><creator>Peters, Mike J L</creator><creator>Nurmohamed, Michael T</creator><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130319</creationdate><title>Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?</title><author>Peters, Mike J L ; Nurmohamed, Michael T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-a22c1ded96274ff21605b75494313e816ec5bab033b209937567b2715c0533a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Practice Patterns, Physicians' - statistics & numerical data</topic><topic>Primary Health Care - statistics & numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peters, Mike J L</creatorcontrib><creatorcontrib>Nurmohamed, Michael T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Arthritis research & therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peters, Mike J L</au><au>Nurmohamed, Michael T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?</atitle><jtitle>Arthritis research & therapy</jtitle><addtitle>Arthritis Res Ther</addtitle><date>2013-03-19</date><risdate>2013</risdate><volume>15</volume><issue>2</issue><spage>111</spage><epage>111</epage><pages>111-111</pages><issn>1478-6354</issn><eissn>1478-6362</eissn><abstract>Rheumatoid arthritis (RA) is associated with a similar cardiovascular risk to that in diabetes, and therefore cardiovascular risk management (CV-RM) - that is, identification and treatment of cardiovascular risk factors (CRFs) - is mandatory. However, whether and to what extent this is done in daily clinical practice is unknown. In a retrospective cohort investigation, CV-RM was therefore compared between rheumatologists and primary care physicians (PCPs). Remarkably, CRFs in RA were less frequently identified and managed by rheumatologists in comparison with PCPs. In addition, PCPs assessed CRFs less frequently in RA than in diabetes. Obviously, there is a clear need for improvement of CV-RM in RA and this should be a joint effort from the rheumatologist and the PCP.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>23514404</pmid><doi>10.1186/ar4185</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1478-6354 |
| ispartof | Arthritis research & therapy, 2013-03, Vol.15 (2), p.111-111 |
| issn | 1478-6354 1478-6362 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3672756 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central; SpringerLink Journals - AutoHoldings |
| subjects | Arthritis, Rheumatoid - drug therapy Cardiovascular Diseases - drug therapy Diabetes Mellitus, Type 2 - drug therapy Female Humans Male Practice Patterns, Physicians' - statistics & numerical data Primary Health Care - statistics & numerical data |
| title | Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T09%3A46%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20risk%20management%20in%20rheumatoid%20arthritis:%20are%20we%20still%20waiting%20for%20the%20first%20step?&rft.jtitle=Arthritis%20research%20&%20therapy&rft.au=Peters,%20Mike%20J%20L&rft.date=2013-03-19&rft.volume=15&rft.issue=2&rft.spage=111&rft.epage=111&rft.pages=111-111&rft.issn=1478-6354&rft.eissn=1478-6362&rft_id=info:doi/10.1186/ar4185&rft_dat=%3Cproquest_pubme%3E1551022100%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551022100&rft_id=info:pmid/23514404&rfr_iscdi=true |